CHARLOTTESVILLE, Va., March 18 -- The University of Virginia issued the following news release:
Acute myeloid leukemia remains a deadly cancer affecting thousands each year. A newly approved drug, ziftomenib, offers a targeted treatment option for some patients. (Illustration by John DiJulio, University Communications)
Whitelaw Reid
Manager of Strategic Communications University of Virginia Licensing & Ventures Group
wdr4d@virginia.edu
434-982-3791
Disclaimer: Curated by HT Syndication....